跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TALZENNA talazoparib (as tosilate) 0.5 mg capsule bottle
Approved
STANDARD
TALZENNA talazoparib (as tosilate) 0.5 mg capsule bottle
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
aa7cdcb4b95278eb
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
aa7cdcb4b95278eb
Product Name
TALZENNA talazoparib (as tosilate) 0.5 mg capsule bottle
Artg Id
407814
Artg Name
TALZENNA talazoparib (as tosilate) 0.5 mg capsule bottle
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2024-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b7e3ff96ba62571f0798cc5c73cff4db.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9445f060fbd3575b617afaffd04a5678.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
aa7cdcb4b95278eb
Type
Standard
Back to TGA Approvals
TALZENNA talazoparib (as tosilate) 0.5 mg capsule bottle - TGA Drug Approval Details
